Innovative insomnia therapies are transforming and driving the insomnia market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Insomnia Market Over The 2026–2030 Period?

The market for insomnia has experienced substantial expansion in recent years. This sector is projected to climb from $5.22 billion in 2025 to $5.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.7%. Throughout the past, this growth was primarily driven by the increasing incidence of sleep disorders, heightened stress levels and evolving lifestyles, the extensive adoption of benzodiazepines and sedatives, improving rates of insomnia diagnosis, and the proliferation of sleep clinics and specialized professionals.

The insomnia market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $7.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.3%. This projected increase is driven by factors such as the greater acceptance of digital therapeutics, the rising need for safer, long-term remedies for insomnia, an expanding elderly population, heightened awareness regarding mental health, and broader availability of online and retail pharmacies. Key developments during this period will encompass a growing embrace of non-pharmacological methods for treating insomnia, increased application of cognitive behavioral therapy for insomnia, a stronger inclination towards tailored sleep management, broader implementation of combination therapy strategies, and an increased understanding of chronic insomnia as a genuine medical condition.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

What Primary Drivers Are Shaping The Insomnia Market?

The rising occurrence of chronic illnesses is anticipated to fuel the expansion of the insomnia market in the future. A chronic disease is defined as a long-term ailment persisting for three months or longer, with the potential to worsen over time. People living with chronic conditions, including cardiovascular disorders, diabetes, and persistent pain, frequently encounter insomnia or other sleep disturbances as an associated condition. This growing incidence generates a need for efficacious treatments and management approaches for insomnia, thus propelling the market for items and services intended to tackle sleep disorders. For example, in April 2025, data from the Centers for Disease Control and Prevention, a US federal public health agency, indicated that 76.4% of US adults, totaling approximately 194 million individuals, reported experiencing at least one chronic condition in 2023. The prevalence rates were 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the growing occurrence of chronic illnesses is boosting the expansion of the insomnia market.

How Is The Insomnia Market Segmented Across Different Segment Categories?

The insomnia market covered in this report is segmented –

1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy

2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy

2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements

What Trends Are Affecting The Growth Of The Insomnia Market?

Major companies in the insomnia market are actively developing new offerings, such as zaleplon-based insomnia drugs, to secure a competitive advantage. Zaleplon serves as a non-benzodiazepine sedative-hypnotic medication prescribed for the short-term management of insomnia. For instance, in April 2023, Bukwang Pharm Co Ltd., a South Korea-based pharmaceutical entity, introduced Zaledeep Cap., which is the first insomnia treatment in South Korea to utilize zaleplon as its primary ingredient. Zaleplon, a non-benzodiazepine drug approved by the FDA for insomnia, is noted for its rapid onset of action, short half-life, and minimal disturbance to daily routines. With the increasing incidence of insomnia in modern society, the launch of Zaledeep Cap. is expected to present a novel and effective treatment pathway, aiming to enhance sleep quality and overall well-being for individuals experiencing insomnia.

Which Organizations Play A Role In The Insomnia Market Landscape?

Major companies operating in the insomnia market are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.

Get The Full Insomnia Market Report:

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Where Is The Insomnia Market Most Concentrated Geographically?

North America was the largest region in the insomnia market in 2025. The regions covered in the insomnia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Insomnia Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Browse Through More Reports Similar to the Global Insomnia Market 2026, By The Business Research Company

Sleep Monitoring Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleep-monitoring-apps-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

Dental Sleep Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-sleep-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795